Assessment of web based case studies

One of the Podiatry Board of Australia’s (Board) stated requirements for an Endorsement for Scheduled Medicine (ESM) for Pathway 2 is the completion of 15 Board approved web-based case studies. These written case studies are expected to cover a range of pathologies relevant to podiatry, and require applicants to review and extend their knowledge to prescription of medicines across the Board’s National Podiatry Scheduled Medicines List.

 

The Board requires that the web-based case studies be undertaken after completion of an approved program of study in podiatric therapeutics but prior to commencing the requirements for supervised practice for ESM as set out in the Board’s Podiatry endorsement for scheduled medicines registration standard http://www.podiatryboard.gov.au/Registration-Standards.aspx

 

From May 2015, ANZPAC will undertake the assessment of web-based case studies developed by education providers and make a recommendation for their approval to the Board.

 

How to Apply

Read the Creating and submitting web based case studies information guide. This guide will assist education providers to develop web based case studies that meet the requirements of the Board’s Podiatry endorsement for scheduled medicines registration standard.

 

Complete the Application form for assessment of web-based case studies by education providers. Applications can be submitted electronically.

 

The cost of the assessment is $2,500. The assessment of web-based case studies by education providers can take up to six (6) weeks from the date ANZPAC receives your correctly completed application form and all the required documents exactly as stated in the form.

 

The outcome of assessment will be submitted to the Board for decision. On receipt of the Board’s decision, ANZPAC will communicate the decision back to the education provider. The outcome of the decision will have a currency of three years, after which time education providers will be required to have their resource reassessed.